Healthcare Law Editing and Proofreading Services

In healthcare, one fact usually has to be written three times. The regulator reads a policy and asks whether it meets the standard. The nurse reads it at three in the morning and asks what to do next. The patient reads a form in a waiting room, without their glasses, and asks what is about to happen to them. Three documents, three registers, one underlying set of facts, and they have to agree. Most of what an editor does in this field comes down to that: keeping the three versions consistent while letting each one sound like it was written for the person actually holding it.

Policies and procedures make up most of the healthcare work that reaches us. Consent forms arrive with them, along with notices of privacy practices and privacy policies, medical staff bylaws, accreditation and survey material, research protocols and consent documents, business associate and affiliation agreements, and incident and disclosure documentation.

Research consent is the place where the standard is written most explicitly, and it is worth quoting because it reads like editorial instruction. Information given to a subject "shall be in language understandable to the subject or the legally authorized representative."1 Consent "must begin with a concise and focused presentation of the key information that is most likely to assist a prospective subject" in understanding why they might or might not take part, and "this part of the informed consent must be organized and presented in a way that facilitates comprehension."1 The document as a whole "must be organized and presented in a way that does not merely provide lists of isolated facts."1 A form that opens with a page of institutional preamble before reaching what the study involves has not begun with the key information, whatever else it contains. Reordering a document so the important part comes first is an editorial change, not a scientific one, and it is often the single largest improvement available.

Two more documents carry a plain-language requirement in the rule's own words. A notice of privacy practices "must provide a notice that is written in plain language",2 and a breach notification to affected individuals "shall be written in plain language."3 Neither says clear, accessible, or reader-friendly. They say plain, and they say it about documents that are usually assembled from templates written by people protecting an institution from a different risk. The result reads as though it were addressed to a lawyer, because it was.

Policies have a different test, and it is a practical one. Somebody will look at this document once, under pressure, to answer a specific question, and the question is almost always what do I do now. That favors numbered steps in the order they happen, one action per step, an actor named in every step, exceptions marked as exceptions rather than folded into the sentence they modify, and headings that describe situations rather than topics. It also favors putting the escalation path where a reader will find it in a hurry. None of this changes what the policy requires. It changes whether the requirement can be followed at the moment it matters.

Disclosure language repays attention for a related reason. A covered entity "must make reasonable efforts to limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request."4 Where an internal policy says information may be shared "as needed" or "as appropriate", the policy has restated the question rather than answered it. An editor cannot supply the limit, because the limit is a decision about practice. What an editor can do is mark every place the document uses a phrase of that kind, so somebody who knows can decide whether a real boundary belongs there.

Consistency across the set is the work that nobody is assigned and everybody assumes has been done. The retention period in the privacy policy, the period in the notice of privacy practices, and the period in the business associate agreement are three statements about one practice. So are the categories of information in a consent form and the categories in the protocol it belongs to. These documents are drafted at different times by different people, and they drift. We read them against each other and report the differences rather than resolving them.

We do not assess regulatory compliance. Whether a policy meets a standard, whether a disclosure is permitted, whether a consent form covers what the protocol does, and whether an incident is reportable are determinations for counsel, the privacy officer, and the clinical leadership, and they reach us made. We do not alter clinical terminology, drug names, doses, or any figure. Where two documents disagree, both come back with the difference set out.

Everything sent to us is treated as strictly confidential. Where a document does not need patient identifiers in order to be edited, we would rather not receive them, and we are glad to work from a version with them removed.

References

  1. Office of the Federal Register, Electronic Code of Federal Regulations, 45 CFR 46.116, General requirements for informed consent, current as of August 2026. https://www.ecfr.gov/current/title-45/section-46.116
  2. Office of the Federal Register, Electronic Code of Federal Regulations, 45 CFR 164.520(b)(1), Notice of privacy practices for protected health information, current as of August 2026. https://www.ecfr.gov/current/title-45/section-164.520
  3. Office of the Federal Register, Electronic Code of Federal Regulations, 45 CFR 164.404(c)(2), Notification to individuals, current as of August 2026. https://www.ecfr.gov/current/title-45/section-164.404
  4. Office of the Federal Register, Electronic Code of Federal Regulations, 45 CFR 164.502(b), Uses and disclosures of protected health information: general rules, current as of August 2026. https://www.ecfr.gov/current/title-45/section-164.502

A worked example: Key Information Section of a Research Consent Form

Research consent form, opening section

The rule asks that informed consent begin with a concise and focused presentation of the key information most likely to help someone decide whether to take part, organized in a way that facilitates comprehension, and that the document as a whole not merely provide lists of isolated facts. The draft below is accurate and begins with the institution. A prospective participant reaches the first sentence describing what would actually happen to them in the fourth line, and reaches the randomization, which is the fact most likely to affect the decision, not at all. Every figure in the revision comes from the protocol record reproduced in both panels. The two numbers the record leaves open are queried rather than supplied, and no risk, procedure or eligibility statement is altered.

Before

SPECIMEN, PREPARED BY EDITFAST FOR ILLUSTRATION. NOT A REAL CONSENT FORM.
Ashgrove Regional Medical Center (fictitious), study of a physiotherapy protocol after knee replacement.

EXTRACT FROM THE PROTOCOL RECORD (reproduced unchanged in both panels)
PR-1 Participants are randomized 1:1 to the study protocol or to the center's usual physiotherapy.
PR-2 Participants are not told which group they are in until the study ends.
PR-3 Duration is 14 weeks: 12 weeks of sessions and a follow-up visit at week 14.
PR-4 Twenty-two clinic visits in total.
PR-5 Known risks are temporary increased knee pain and swelling after sessions, reported by roughly one participant in four in the pilot.
PR-6 There is no direct benefit to participants. The protocol says so expressly.
PR-7 Participation is voluntary and may be stopped at any time without affecting the participant's care.
PR-8 Travel costs are reimbursed. The protocol does not state a per-visit amount.
PR-9 The protocol does not state how long identifiable data is kept after the study closes.

ABOUT THIS RESEARCH STUDY

Ashgrove Regional Medical Center has a longstanding commitment to advancing the quality of orthopedic care through rigorous clinical research, and our Department of Rehabilitation Medicine has conducted studies in this area for over twenty years. This study has been reviewed and approved by the Institutional Review Board in accordance with all applicable federal regulations and institutional policies governing the protection of human subjects. You are being invited to participate because you are scheduled to undergo a total knee replacement procedure and meet the eligibility criteria set forth in the study protocol. The purpose of this research is to evaluate a physiotherapy protocol. If you agree to participate, you will be asked to attend clinic visits over a period of time and to complete assessments. Some participants may experience discomfort. Your participation is entirely voluntary. Please read the following pages carefully and discuss any questions with the study team before signing.

After

SPECIMEN, PREPARED BY EDITFAST FOR ILLUSTRATION. NOT A REAL CONSENT FORM.
Ashgrove Regional Medical Center (fictitious), study of a physiotherapy protocol after knee replacement.

EXTRACT FROM THE PROTOCOL RECORD (reproduced unchanged in both panels)
PR-1 Participants are randomized 1:1 to the study protocol or to the center's usual physiotherapy.
PR-2 Participants are not told which group they are in until the study ends.
PR-3 Duration is 14 weeks: 12 weeks of sessions and a follow-up visit at week 14.
PR-4 Twenty-two clinic visits in total.
PR-5 Known risks are temporary increased knee pain and swelling after sessions, reported by roughly one participant in four in the pilot.
PR-6 There is no direct benefit to participants. The protocol says so expressly.
PR-7 Participation is voluntary and may be stopped at any time without affecting the participant's care.
PR-8 Travel costs are reimbursed. The protocol does not state a per-visit amount.
PR-9 The protocol does not state how long identifiable data is kept after the study closes.

KEY INFORMATION

You are being invited to take part in a research study because you are scheduled for a total knee replacement. Here is what matters most in deciding. The rest of this form gives the detail.

What the study is testing. Whether a different physiotherapy protocol works better than the physiotherapy this center normally provides after knee replacement.

Which one you would get. A computer would assign you at random, with an equal chance of each. You would not be told which group you are in until the study ends.

What it would involve. Twenty-two clinic visits over 14 weeks: 12 weeks of sessions and a follow-up visit at week 14.

What could go wrong. Your knee may hurt more and swell after sessions. In our earlier study about one participant in four had this. It was temporary.

What you would get out of it. Nothing directly. This study is designed to find out whether the protocol helps future patients, not to give you better treatment than you would otherwise receive.

Whether you have to. No. Taking part is your choice, you can stop at any time, and your care here will be exactly the same either way.

We reimburse your travel costs [amount per visit].

[Two points for the study team.
1. PR-8 records that travel costs are reimbursed but sets no per-visit amount. A participant deciding whether they can afford 22 visits needs the figure. Please supply it.
2. PR-9 does not say how long identifiable data is kept after the study closes. That belongs in the privacy section of this form and we have no basis to state it.]

What changed, and why

WasNowReason
Ashgrove Regional Medical Center has a longstanding commitment to advancing the quality of orthopedic care ... for over twenty years.(removed)Forty-two words about the institution at the point where the rule asks for the key information most likely to assist the decision. Nothing in it bears on whether to take part.
This study has been reviewed and approved by the Institutional Review Board in accordance with all applicable federal regulations(moved to the body of the form)True, and it reassures the reader, but it is not among the facts that decide the question. It belongs later rather than in the opening section.
(randomization not mentioned)A computer would assign you at random, with an equal chance of each. You would not be told which group you are in until the study ends.PR-1 and PR-2 record the two facts most likely to change a decision, and the draft omitted both. Somebody agreeing to this form as written would not know they might receive the usual care.
you will be asked to attend clinic visits over a period of time and to complete assessmentsTwenty-two clinic visits over 14 weeks: 12 weeks of sessions and a follow-up visit at week 14.PR-3 and PR-4 give both numbers. A period of time is not a burden anyone can weigh, and the burden is the whole question for a person deciding whether they can manage it.
Some participants may experience discomfort.Your knee may hurt more and swell after sessions. In our earlier study about one participant in four had this. It was temporary.PR-5 gives the symptoms, the rate and the duration. Discomfort is a softer word than the protocol's own, and the rate is the part that lets a reader judge the risk.
The purpose of this research is to evaluate a physiotherapy protocol.Whether a different physiotherapy protocol works better than the physiotherapy this center normally provides after knee replacement.Evaluate a protocol does not say what the comparison is, and the comparison is the study.
(benefit not addressed)Nothing directly. This study is designed to find out whether the protocol helps future patientsPR-6 records expressly that there is no direct benefit. Leaving it out of the key information invites the assumption that participants get better treatment, which is the most common misunderstanding these forms create.
Your participation is entirely voluntary.No. Taking part is your choice, you can stop at any time, and your care here will be exactly the same either way.PR-7 records all three elements. Voluntary is a term of art; the fear it is meant to answer is that refusing will affect their care, and the form should answer that fear in words.
(no headings)seven questions as headings, each answered underneathThe rule asks for a presentation organized to facilitate comprehension and warns against a list of isolated facts. Questions a person is actually asking, answered in order, is the organization the section was missing.
(travel reimbursement and data retention absent)[Two points for the study team ...]PR-8 and PR-9 record both as unsettled in the protocol. An editor cannot invent a reimbursement rate or a retention period, and both are things a participant is entitled to know before signing.

Specimen prepared by EditFast for illustration only. Not a real document, record or filing. Any resemblance to an actual organization, person or record is unintended. Not legal, regulatory, clinical or professional advice.

Key Healthcare Law vocabulary

Informed consent
agreement to treatment or to research given after being told, in language the person can understand, what it involves and what could happen. A signature on a form the person could not read does not satisfy it.
Key information
the concise opening section a research consent form is required to begin with, presenting what is most likely to help someone decide. It has to be organized for comprehension, which makes its order an editorial matter.
Capacity
the ability to understand a decision and its consequences. Assessed for the specific decision at hand, not as a general status.
Legally authorized representative
the person permitted to consent on behalf of someone who cannot. Who qualifies is set by state law, so a national form has to be careful how it names them.
Advance directive
a person's written instructions about future care, taking effect if they cannot speak for themselves.
Standard of care
the level of skill and caution the profession expects in the circumstances. What a policy requires and what the standard requires are related but not the same, and documents sometimes treat them as identical.
Scope of practice
what a given license permits its holder to do. Policies that assign a task without naming who may perform it leave this unanswered at the point of use.
Protected health information
individually identifiable health information held or transmitted by a covered entity or its business associate. Broader than a medical record; a scheduling note can qualify.
Covered entity
a health plan, health care clearinghouse, or provider that transmits health information electronically for certain transactions. The label determines which obligations apply.
Business associate
an outside party that handles protected health information on a covered entity's behalf. The relationship has to be governed by a written agreement.
Business associate agreement
that written contract, setting out permitted uses and safeguards. Its terms should match what the notice of privacy practices tells patients, and often do not.
Minimum necessary
the requirement to limit the information used, disclosed or requested to what the purpose actually needs. "As appropriate" in a policy restates the question rather than answering it.
Notice of privacy practices
the document telling patients how their health information may be used and disclosed. Required by rule to be written in plain language, which is unusual and is meant literally.
Authorization
a patient's signed permission for a use or disclosure not otherwise allowed. Distinct from consent to treatment, and the two are frequently confused in drafting.
Breach notification
the required notice to affected individuals after a breach of unsecured protected health information. Also required to be written in plain language, and read under exactly the conditions that make plainness hard.
De-identification
removing identifiers so information is no longer protected health information. Achieved by a defined method, not by judgment, and claimed more often than it is done.
Institutional Review Board
the committee that reviews and approves research involving human subjects, including the consent documents.
Protocol
the document setting out how a study will be conducted. The consent form must not describe something the protocol does not say.
Clinical trial agreement
the contract between sponsor and site governing the conduct of a trial, including publication rights and data handling.
Medical staff bylaws
the governing document for a hospital's medical staff, covering membership, privileges and discipline. Amended by accretion over years, which is why internal cross-references in them so often point nowhere.
Credentialing
verifying a practitioner's qualifications, licensure and history before granting privileges.
Privileges
the specific procedures a practitioner is permitted to perform at a facility. Narrower than their license.
Accreditation
review by an outside body against published standards. Survey documents are read by strangers against a checklist, which rewards structure over narrative.
Adverse event
an unwanted occurrence in the course of care or research. Reportable or not depending on defined criteria, which a policy should state rather than imply.
Sentinel event
a patient safety event resulting in death, permanent harm, or severe temporary harm. Triggers its own review process.
Disclosure of harm
telling a patient that something went wrong in their care. A document written for a frightened reader, and among the hardest registers in the field.
Root cause analysis
the structured review following a serious event, aimed at the system rather than the individual. Its report is read by people who were not there.
Quality assurance
the internal review of care quality, often protected from disclosure by statute. What falls inside that protection depends partly on how documents are labeled and where they are kept.
Vicarious liability
an institution's responsibility for the acts of its staff. One reason policies are written with an eye on the regulator rather than the reader.
State medical board
the body licensing and disciplining physicians in a given state. Responses to it are formal documents with their own deadlines.

Healthcare Law Word Challenge

Even seasoned pros miss these — give it a shot.

Get a Free Estimate

« More Legal editing  |  All editing services